GR3018632T3 - Beta-alethine use in cell culture and therapy. - Google Patents
Beta-alethine use in cell culture and therapy.Info
- Publication number
- GR3018632T3 GR3018632T3 GR960400052T GR960400052T GR3018632T3 GR 3018632 T3 GR3018632 T3 GR 3018632T3 GR 960400052 T GR960400052 T GR 960400052T GR 960400052 T GR960400052 T GR 960400052T GR 3018632 T3 GR3018632 T3 GR 3018632T3
- Authority
- GR
- Greece
- Prior art keywords
- alethine
- beta
- therapy
- cell culture
- treatment
- Prior art date
Links
- WELIVEBWRWAGOM-UHFFFAOYSA-N 3-amino-n-[2-[2-(3-aminopropanoylamino)ethyldisulfanyl]ethyl]propanamide Chemical compound NCCC(=O)NCCSSCCNC(=O)CCN WELIVEBWRWAGOM-UHFFFAOYSA-N 0.000 title abstract 3
- 238000004113 cell culture Methods 0.000 title abstract 2
- 238000002659 cell therapy Methods 0.000 title 1
- 208000026278 immune system disease Diseases 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000004069 differentiation Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 230000009826 neoplastic cell growth Effects 0.000 abstract 1
- 230000036448 vitalisation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0081—Purging biological preparations of unwanted cells
- C12N5/0093—Purging against cancer cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54910390A | 1990-07-06 | 1990-07-06 | |
US54910490A | 1990-07-06 | 1990-07-06 | |
PCT/US1991/004725 WO1992000960A1 (en) | 1990-07-06 | 1991-07-08 | Beta-alethine use in cell culture and therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3018632T3 true GR3018632T3 (en) | 1996-04-30 |
Family
ID=27069009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR960400052T GR3018632T3 (en) | 1990-07-06 | 1996-01-10 | Beta-alethine use in cell culture and therapy. |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0538330B1 (el) |
JP (1) | JP3319597B2 (el) |
AT (1) | ATE128964T1 (el) |
AU (1) | AU646875B2 (el) |
DE (1) | DE69113802T2 (el) |
DK (1) | DK0538330T3 (el) |
ES (1) | ES2080954T3 (el) |
GR (1) | GR3018632T3 (el) |
WO (1) | WO1992000960A1 (el) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6245561B1 (en) | 1990-07-06 | 2001-06-12 | University Of New Mexico | β-alethine use in cell culture and therapy |
JP3259960B2 (ja) * | 1990-07-06 | 2002-02-25 | ユニバシテイ オブ ニュー メキシコ | 細胞培養及び治療に有用なビタレテイン |
US5643966A (en) * | 1990-07-06 | 1997-07-01 | University Of New Mexico | β-alethine as anti-tumor agent |
WO1994026259A1 (en) * | 1993-05-12 | 1994-11-24 | Oculon Corporation | Chemical prevention or reversal of cataract by phase separation inhibitors |
US6007819A (en) | 1995-10-17 | 1999-12-28 | Dovetail Technologies, Inc. | Methods of inducing immunity using low molecular weight immune stimulants |
WO1999042116A1 (en) | 1998-02-24 | 1999-08-26 | Dovetail Technologies Inc. | Novel disulfides and thiol compounds |
US6762174B1 (en) | 1998-02-24 | 2004-07-13 | Dovetail Technologies, Inc. | Low molecular weight compounds administered together with anti-cancer agents to prevent or treat cancer and pharmaceutical compositions thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4552765A (en) * | 1982-05-14 | 1985-11-12 | Santen Pharmaceutical Co., Ltd. | Aletheine derivatives |
JPS5973515A (ja) * | 1982-10-20 | 1984-04-25 | Santen Pharmaceut Co Ltd | 肝障害抑制剤 |
-
1991
- 1991-07-08 JP JP51211791A patent/JP3319597B2/ja not_active Expired - Fee Related
- 1991-07-08 ES ES91912761T patent/ES2080954T3/es not_active Expired - Lifetime
- 1991-07-08 AU AU82077/91A patent/AU646875B2/en not_active Ceased
- 1991-07-08 EP EP91912761A patent/EP0538330B1/en not_active Expired - Lifetime
- 1991-07-08 WO PCT/US1991/004725 patent/WO1992000960A1/en active IP Right Grant
- 1991-07-08 AT AT91912761T patent/ATE128964T1/de not_active IP Right Cessation
- 1991-07-08 DK DK91912761.3T patent/DK0538330T3/da active
- 1991-07-08 DE DE69113802T patent/DE69113802T2/de not_active Expired - Fee Related
-
1996
- 1996-01-10 GR GR960400052T patent/GR3018632T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK0538330T3 (da) | 1996-02-26 |
EP0538330A1 (en) | 1993-04-28 |
AU8207791A (en) | 1992-02-04 |
JP3319597B2 (ja) | 2002-09-03 |
AU646875B2 (en) | 1994-03-10 |
WO1992000960A1 (en) | 1992-01-23 |
DE69113802D1 (de) | 1995-11-16 |
ES2080954T3 (es) | 1996-02-16 |
JPH05508769A (ja) | 1993-12-09 |
EP0538330A4 (en) | 1993-07-07 |
EP0538330B1 (en) | 1995-10-11 |
DE69113802T2 (de) | 1996-05-15 |
ATE128964T1 (de) | 1995-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9910251A (pt) | Estimulação hematopoiética | |
ATE87214T1 (de) | Verwendung katabolischer enzyme zur herstellung eines medikaments zum bekaempfen der erworbenen immunschwaeche (aids) und deren vorstadien (las, arc). | |
ES2170096T3 (es) | Uso de lineas celulares fetales neuroderivadas para terapia de trasplantes. | |
ES2077530A1 (es) | Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales. | |
DE69535328D1 (de) | In-vitro wachstum von langerhans'schen inseln und ihre verwendungen | |
AU6649996A (en) | Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease | |
ZA91574B (en) | Use of n-myristoyl-(s)-phenylalanine for obtaining medicinal products for the treatment of diseases involving myristoylation | |
ES2151607T3 (es) | Factor 12 de crecimiento y de diferenciacion. | |
GR3018632T3 (en) | Beta-alethine use in cell culture and therapy. | |
HK1055079A1 (en) | Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders | |
CA2098113A1 (en) | Substances of polypeptide nature useful in human therapy | |
HUT58037A (en) | Process for producing n-2,3-butadienyl tri- and tetraaminoalkane derivatives | |
AU4482985A (en) | Pyrro-1-yl-phenyl-dihydropyridazones | |
AU5781886A (en) | Process for the in vitro immunization of human splenocytes against tumor associated antigens | |
ATE141510T1 (de) | Arzneimittel enthaltend cd14 | |
PH23658A (en) | Improved method of treating tumors with autologous lymphokine activated killer,interleukin-2 and an ornithine decarboxylase inhibitor | |
HK1035866A1 (en) | A complex of alpha-fetoprotein (afp) and a polyunsaturated fatty acid derivative for the treatment of immune deficiencies | |
MD1119G2 (ro) | Metodă de tratament al afecţiunilor inflamatorii ale organelor genitale feminine | |
DK0539525T3 (da) | Vitalethein og anvendelse deraf i cellekultur og terapi | |
GEP20012377B (en) | Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases | |
EP0278715A3 (en) | Use of human gamma interferon for treatment of basal cell carcinoma | |
WO2000022097A3 (en) | Periferal blood mensenchymal precursor cells | |
Zamshor et al. | Beef-extract agar with sodium nucleinate as a medium for storage and stabilization of biological properties of shigellas. | |
BG48924A3 (en) | Method for preparing of biologically active means | |
MX9703493A (es) | Induccion in vitro de celulas dopaminergicas. |